Concerta

May 26, 2010

New Data Analyses Of CONCERTA(R) Efficacy On ADHD In The Classroom

Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD),[1] according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA� (OROS� methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children ...

Filed under Main Content by

Spread the Word!

Permalink Print Comment

Study demonstrates efficacy of CONCERTA in treating ADHD in presence of comorbid learning disability

Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA� (OROS� methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with ...

Filed under Main Content by

Spread the Word!

Permalink Print Comment

May 25, 2010

New Data Analyses of CONCERTA(R) Efficacy on ADHD in the Classroom

NEW ORLEANS, May 25 /PRNewswire/ -- Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD),(1) according to the National Institute of Mental Health (NIMH).

Filed under Main Content by

Spread the Word!

Permalink Print Comment

New Data Analyses of CONCERTA(R) Efficacy on ADHD in the Classroom

Clinical trial in a simulated classroom "laboratory school" setting evaluated treatment efficacy on ADHD symptoms and specific challenges read more

Filed under Main Content by

Spread the Word!

Permalink Print Comment

April 27, 2010

Court denies McNeil Paediatrics appeal over Concerta patent

The Court of Appeals for the Federal Circuit has denied an appeal by McNeil Paediatrics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, to overturn a 2009 decision by the US District Court of Delaware that the patent for Concerta (methylphenidate HCl) Extended-Release Tablets CII is invalid and not infringed by Andrx Corporation.

Filed under Main Content by

Spread the Word!

Permalink Print Comment